The Sackler family and Purdue Pharma have agreed to a $7.4 billion settlement to resolve federal claims brought by attorneys ...

The Sackler family and Purdue Pharma, maker of OxyContin, have increased their settlement offer to $7.4 billion amid ongoing ...

OxyContin maker Purdue Pharma and its owners agreed to pay up to $7.4 billion in a new settlement, officials in Mass. and ...

Massachusetts could receive more than $100 million as part of a tentative new settlement between attorneys general, Purdue ...

The deal represents an increase over a previous settlement rejected by the Supreme Court because it protected members of the ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

New York State will gain up to $250 million from a $7.4 billion settlement with Purdue Pharma and the Sackler family, ...

Prescription opioid overdoses have killed thousands of Utahns. A new settlement puts a price tag on their lives and could bring "justice" to their families." ...

The Sackler family agreed to give up ownership of the company that manufactures the powerful opioid. A previous deal was ...

In the latest twist in its efforts to wrap up years of high-profile opioid litigation, the billionaire family behind the ...

Connecticut and 14 other states on Thursday agreed to a new settlement deal with the Sackler family and Purdue Pharma that ...

Bankrupt Purdue Pharma LP and its owners have agreed to pay $7.4 billion to a group of U.S. states and other parties to settle long-running litigation over OxyContin’s role in the deadly opioid ...